Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Lupin Ltd.
NSE: LUPIN
|
BSE: 500257
|
ISIN: INE326A01037
|
Industry: Pharmaceuticals
US FDA Approval
|
Falling Comet
1951.2000
10.70
(
0.55
%)
NSE
Oct 16, 2025
15:31 PM
Volume:
375.1K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Lupin Ltd.
13 Mar 2025
US FDA Approval
1951.20
0.55%
LUPIN LIMITED
Hold:
Lupin Ltd.
by
Geojit BNP Paribas
Target: 2132 | Target met
Target
Geojit BNP Paribas
Lupin Ltd. has an
average target
of 2326.00 from 8 brokers.
More from Lupin Ltd.
Recommended
Market closes higher, Kajaria Ceramics' Q2 profit beats estimates by 9%
Trendlyne Marketwatch |
16 Oct 2025, 04:04PM
Analysts pick their winners: Five stocks set to shine in Q2FY26
The Baseline |
16 Oct 2025, 11:21AM
Lupin expects normalization by September quarter
|
17 Apr 2020